Isabelle Chemin

4.9k total citations
106 papers, 3.4k citations indexed

About

Isabelle Chemin is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Isabelle Chemin has authored 106 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Epidemiology, 72 papers in Hepatology and 21 papers in Molecular Biology. Recurrent topics in Isabelle Chemin's work include Hepatitis B Virus Studies (78 papers), Hepatitis C virus research (64 papers) and Liver Disease Diagnosis and Treatment (37 papers). Isabelle Chemin is often cited by papers focused on Hepatitis B Virus Studies (78 papers), Hepatitis C virus research (64 papers) and Liver Disease Diagnosis and Treatment (37 papers). Isabelle Chemin collaborates with scholars based in France, United Kingdom and Gambia. Isabelle Chemin's co-authors include Fabien Zoulim, Christian Trépo, Pierre Hainaut, Évelyne Klinger, Alan Kay, Patrick Légeron, Pierre Nugues, Stéphane Roy, Philippe Merle and Christian Trépo and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Isabelle Chemin

103 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Chemin France 34 2.0k 1.7k 749 305 283 106 3.4k
Katrin Neubauer Germany 30 1.1k 0.5× 1.3k 0.8× 716 1.0× 177 0.6× 127 0.4× 50 2.7k
Hiroshi Shirasawa Japan 31 1.0k 0.5× 236 0.1× 720 1.0× 398 1.3× 189 0.7× 120 2.7k
Christopher Mee United Kingdom 21 636 0.3× 705 0.4× 572 0.8× 52 0.2× 65 0.2× 31 1.7k
Nobuo Ohta Japan 32 528 0.3× 125 0.1× 409 0.5× 28 0.1× 11 0.0× 121 3.2k
Yuki Ogura Japan 18 750 0.4× 899 0.5× 393 0.5× 95 0.3× 26 0.1× 62 1.9k
Hironori Sato Japan 37 1.1k 0.6× 148 0.1× 1.1k 1.5× 245 0.8× 105 0.4× 193 4.7k
Ioannis Bossis United States 35 683 0.3× 70 0.0× 1.0k 1.4× 371 1.2× 150 0.5× 83 3.3k
Jan Stindt Germany 15 800 0.4× 550 0.3× 288 0.4× 491 1.6× 20 0.1× 29 1.6k
Peter Hull Canada 28 893 0.4× 206 0.1× 326 0.4× 177 0.6× 20 0.1× 124 2.5k

Countries citing papers authored by Isabelle Chemin

Since Specialization
Citations

This map shows the geographic impact of Isabelle Chemin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Chemin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Chemin more than expected).

Fields of papers citing papers by Isabelle Chemin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Chemin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Chemin. The network helps show where Isabelle Chemin may publish in the future.

Co-authorship network of co-authors of Isabelle Chemin

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Chemin. A scholar is included among the top collaborators of Isabelle Chemin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Chemin. Isabelle Chemin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chemin, Isabelle, et al.. (2024). Triple burden of hepatitis B, hepatitis Delta viruses, and Plasmodium falciparum to pregnant women. IJID Regions. 13. 100447–100447.
2.
3.
Loureiro, Carmen L., et al.. (2023). The Hepatitis B Virus Genotypes E to J: The Overlooked Genotypes. Microorganisms. 11(8). 1908–1908. 3 indexed citations
4.
Gérossier, Laetitia, A. Dubois, Nadim Farés, et al.. (2020). PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles’ heel?. Clinics and Research in Hepatology and Gastroenterology. 45(5). 101553–101553. 12 indexed citations
5.
Tout, Issam, Michelle Ainouze, Marie Marotel, et al.. (2018). Hepatitis B Virus Blocks the CRE/CREB Complex and Prevents TLR9 Transcription and Function in Human B Cells. The Journal of Immunology. 201(8). 2331–2344. 23 indexed citations
6.
Berby, Françoise, Isabelle Bordes, O. Hantz, et al.. (2017). Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes. PLoS ONE. 12(6). e0179697–e0179697. 24 indexed citations
7.
Tout, Issam, et al.. (2017). HBV and the importance of TLR9 on B cell responses. SHILAP Revista de lepidopterología. 1(3). 124–137. 1 indexed citations
8.
Favaudon, Vincent, Zdenko Herceg, Charlotte Sagne, et al.. (2014). PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitrohepatocellular carcinoma models. BMC Cancer. 14(1). 603–603. 41 indexed citations
9.
Robert, Philippe, Sandrine Andrieu, François Brémond, et al.. (2013). Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD expert meeting. The journal of nutrition health & aging. 17(8). 653–660. 30 indexed citations
10.
Feydi, Abdellah Essaid El, Mustapha Benazzouz, Khadija Rebbani, et al.. (2011). Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. Journal of Infection. 63(1). 66–75. 42 indexed citations
11.
Paliwal, Anupam, David Durantel, Pierre Hainaut, et al.. (2010). DNA Methylation of Hepatitis B Virus (HBV) Genome Associated with the Development of Hepatocellular Carcinoma and Occult HBV Infection. The Journal of Infectious Diseases. 202(5). 700–704. 50 indexed citations
12.
Tavares‐Neto, José, et al.. (2008). Occult B infection in the Brazilian northeastern region: a preliminary report. The Brazilian Journal of Infectious Diseases. 12(4). 310–312. 5 indexed citations
13.
Chemin, Isabelle. (2007). Molecular basis of hepatitis C virus -associated hepatocarcinogenesis. SHILAP Revista de lepidopterología. 3 indexed citations
14.
Klinger, Évelyne, et al.. (2006). Virtual Action Planning in Parkinson's Disease: AControl Study. CyberPsychology & Behavior. 9(3). 342–347. 63 indexed citations
15.
Klinger, Évelyne, Stéphane Bouchard, Patrick Légeron, et al.. (2005). Virtual Reality Therapy Versus Cognitive Behavior Therapy for Social Phobia: A Preliminary Controlled Study. CyberPsychology & Behavior. 8(1). 76–88. 222 indexed citations
16.
Roy, Stéphane, et al.. (2003). Definition of a VR-Based Protocol to Treat Social Phobia. CyberPsychology & Behavior. 6(4). 411–420. 58 indexed citations
17.
Légeron, Patrick, S. Roy, Évelyne Klinger, et al.. (2003). Thérapie par réalité virtuelle dans la phobie sociale : Etude préliminaire auprès de 36 patients. Journal de Thérapie Comportementale et Cognitive. 13(3). 113–127. 1 indexed citations
18.
Chemin, Isabelle, Fabien Zoulim, Philippe Merle, et al.. (2001). High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. Journal of Hepatology. 34(3). 447–454. 141 indexed citations
19.
Chemin, Isabelle, et al.. (2001). Role of silent hepatitis B virus in chronic hepatitis B surface antigen(−) liver disease. Antiviral Research. 52(2). 117–123. 42 indexed citations
20.
Chemin, Isabelle, Claudine Vermot‐Desroches, O. Hantz, et al.. (1992). Demonstration of woodchuck hepatitis virus infection of peripheral blood mononuclear cells by flow cytometry and polymerase chain reaction. Journal of General Virology. 73(1). 123–129. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katrin Neubauer Breakdown of academic impact, for papers by Hiroshi Shirasawa Breakdown of academic impact, for papers by Christopher Mee Breakdown of academic impact, for papers by Nobuo Ohta Breakdown of academic impact, for papers by Yuki Ogura Breakdown of academic impact, for papers by Hironori Sato Breakdown of academic impact, for papers by Ioannis Bossis Breakdown of academic impact, for papers by Jan Stindt Breakdown of academic impact, for papers by Peter Hull
Rankless by CCL
2026